{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:31:38Z","timestamp":1789810298047,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.diagmicrobio.2003.10.003","type":"journal-article","created":{"date-parts":[[2004,1,7]],"date-time":"2004-01-07T10:37:08Z","timestamp":1073471828000},"page":"153-160","source":"Crossref","is-referenced-by-count":69,"title":["The role of antifungal susceptibility testing in the therapy of candidiasis"],"prefix":"10.1016","volume":"48","author":[{"given":"Duane R","family":"Hospenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton K","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jac\/47.5.521","article-title":"Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates","volume":"47","author":"Arendrup","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1439-0507.1997.tb00234.x","article-title":"Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients","volume":"40","author":"Arikan","year":"1997","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1086\/513927","article-title":"Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis","volume":"26","author":"Arikan","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB4","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/JCM.38.9.3457-3459.2000","article-title":"Quality control limits for broth microdilution susceptibility tests of ten antifungal agents","volume":"38","author":"Barry","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/AAC.46.6.1781-1784.2002","article-title":"Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods","volume":"46","author":"Barry","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB6","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1128\/JCM.39.11.4181-4183.2001","article-title":"Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998","volume":"39","author":"Chryssanthou","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB7","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1128\/JCM.40.10.3841-3844.2002","volume":"40","author":"Chryssanthou","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/AAC.43.5.1289","article-title":"Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B","volume":"43","author":"Clancy","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB9","doi-asserted-by":"crossref","unstructured":"Cuenca-Estrella, M., Moore, C. B., Barchiesi, F., Bille, J., Chryssanthou, E., Denning, D. W., Donnelly, J. P., Dromer, F., Dupont, B., Rex, J. H., Richardson, M. D., Sancak, B., Verweij, P. E., Rodr\u00edguez-Tudela, J. L. and the AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Clin Microbiol Infect 9, 467\u2013474","DOI":"10.1046\/j.1469-0691.2003.00592.x"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/375080","article-title":"Caspofungin","volume":"36","author":"Deresinski","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB11","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1128\/AAC.45.11.3231-3233.2001","article-title":"Fungal phospholipase activity and susceptibility to lipid preparations of amphotericin B","volume":"45","author":"Gottfredsson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB12","first-page":"22","article-title":"A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B","volume":"12","author":"Jessup","year":"2000","journal-title":"J Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1439-0507.2000.00574.x","article-title":"Comparison of Etest with the broth microdilution method in susceptibility testing of yeast isolates against four antifungals","volume":"43","author":"Koc","year":"2000","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s101560070006","article-title":"Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population","volume":"6","author":"Kovacicova","year":"2000","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhin.2001.1151","article-title":"Non-albicans Candida spp. causing fungaemia","volume":"50","author":"Krcmery","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB16","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB17","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/AAC.44.10.2715-2718.2000","article-title":"Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole","volume":"44","author":"Lee","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jac\/43.4.477","article-title":"A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp","volume":"43","author":"Mart\u00edn-Mazuelos","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.47.5.1647-1651.2003","article-title":"Correlation between E-Test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole","volume":"47","author":"Matar","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1128\/JCM.41.3.1087-1090.2003","article-title":"Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood","volume":"41","author":"Maxwell","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB21","doi-asserted-by":"crossref","unstructured":"Morace, G., Amato, G., Bistoni, F., Fadda, G., Marone, P., Montagna, M. T., Oliveri, S., Polonelli, L., Rigoli, R., Muncuso, I., La Face, S., Masucci, L., Romano, L., Napoli, C., Tat\u00f2, D., Buscema, M. G., Belli, C. M. C., Piccirillo, M. M., Conti, S., Covan, S., Fanti, F., Cavanna, C., D'Al\u00f2, F., & Pitzurra, L. (2002). Multicenter comparative evaluation of six commercial systems and the National Committee for Clinical Laboratory Standards M27-A. broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol 40, 2953\u20132958","DOI":"10.1128\/JCM.40.8.2953-2958.2002"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB22","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard","year":"1997"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB23","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB24","series-title":"Method for antifungal disk diffusion susceptibility testing of yeasts; proposed guideline","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/514193","article-title":"Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia","volume":"177","author":"Nguyen","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/376634","article-title":"Amphotericin B","volume":"37","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB27","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","article-title":"International surveillance of bloodstream infections due to Candida species","volume":"39","author":"Pfaller","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB28","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1128\/AAC.47.3.1068-1071.2003","article-title":"In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3, 959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates","volume":"47","author":"Pfaller","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0732-8893(98)00120-5","article-title":"Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B","volume":"32","author":"Pfaller","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB30","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1128\/JCM.38.10.3715-3717.2000","article-title":"Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media","volume":"38","author":"Pfaller","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB31","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1128\/JCM.36.9.2586-2589.1998","article-title":"Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media","volume":"36","author":"Pfaller","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB32","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0891-5520(05)70192-6","article-title":"Antifungal susceptibility testing. New technology and clinical applications","volume":"15","author":"Pfaller","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1198-743x.2001.00307.x","article-title":"Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals","volume":"7","author":"Pina-Vaz","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0732-8893(00)00174-7","article-title":"Commercial systems for fluconazole susceptibility testing of yeasts","volume":"38","author":"Posteraro","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0002-9343(88)90059-9","article-title":"Amphotericin B-resistant yeast infection in severely immunocompromised patients","volume":"84","author":"Powderly","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/AAC.39.1.40","article-title":"Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/CMR.6.4.367","article-title":"Antifungal susceptibility testing","volume":"6","author":"Rex","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB39","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1128\/AAC.45.7.2129-2133.2001","article-title":"Prospective study of Candida species in patients at a comprehensive cancer center","volume":"45","author":"Safdar","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/JCM.40.3.918-921.2002","article-title":"Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory","volume":"40","author":"Vandenbossche","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2003.10.003_BIB41","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JCM.39.7.2458-2462.2001","article-title":"Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome","volume":"39","author":"Wenisch","year":"2001","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T18:13:11Z","timestamp":1585419191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889303002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0732889303002232"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2003.10.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}